Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 1, 1997
Endoscopists' opinions of indications for upper gastrointestinal endoscopyL R Sutherland, M J Verhoef, J B Meddings, et al.Gut|December 22, 1999
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsiaN P Breslin, A B Thomson, R J Bailey, et al.The American Journal of Gastroenterology|May 16, 2000
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleedingG M Van Rosendaal, L R Sutherland, M J Verhoef, et al.Alimentary Pharmacology & Therapeutics|September 3, 2010
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohortA W G Waugh, S Garg, K Matic, et al.The American Journal of Gastroenterology|December 22, 1998
The utility of endoscopy in the management of patients with gastroesophageal reflux symptomsP K Blustein, P L Beck, J B Meddings, et al.Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.Alimentary Pharmacology & Therapeutics|February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's diseaseB G Feagan, W J Sandborn, J P Baker, et al.Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.Pageof 10